SRA's number for the day: 204
This article was originally published in SRA
Executive Summary
The report, minutes and oral and written evidence that a UK parliamentary committee published on 17 September on the shortcomings of the clinical trials environment run to 204-pages1,2.
You may also be interested in...
Next-Gen CAR T & Novel SMA Drug Among New Entrants On EMA’s PRIME
Autolus, Scholar Rock, Rocket and Pfizer have managed to convince the European Medicines Agency that their investigational treatments merit a place on the regulator’s priory medicines scheme.
New Zealand To Align GMP Audits With Best Practices Overseas
Companies operating in New Zealand will have six months to transition to Medsafe’s updated code on good manufacturing practice.
Alexion Secures Funding OK In England For GI Bleeding But Wants More
Alexion is collecting more evidence to convince NICE that its anticoagulant reversal agent is also cost-effective for intracranial hemorrhage.